Navigation Links
LCA-Vision to Present at RBC Capital Markets' 2008 Healthcare Conference
Date:12/2/2008

CINCINNATI, Dec. 2 /PRNewswire-FirstCall/ -- LCA-Vision Inc. (Nasdaq: LCAV), a leading provider of laser vision correction services under the LasikPlus(R) brand, today announced that members of its executive management team will present at RBC Capital Markets' 2008 Healthcare Conference on Thursday, December 11, 2008 at 9:00 a.m. Eastern time. The conference is being held at The Westin Times Square in New York City. A live and archived webcast of the event will be available at the Investor Relations section of LCA-Vision's Web site at http://www.lasikplus.com/webcast/.

About LCA-Vision Inc./LasikPlus(R)

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus(R) brand, operates 77 LasikPlus(R) fixed-site laser vision correction centers in 33 states and 59 markets in the United States and a joint venture in Canada. Additional company information is available at www.lca-vision.com and www.lasikplus.com.

    Earning Trust Every Moment.

    Transforming Lives Every Day.

    For Additional Information

    Company Contact:                    Investor Relations Contact:
    Barb Kise                           Jody Cain
    LCA-Vision Inc.                     Lippert/Heilshorn & Associates
    513-792-9292                        310-691-7100

'/>"/>
SOURCE LCA-Vision Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. 11.4% Shareholders & Former Executive Management of LCA-Vision Express Shock and Disbelief at Recent Adoption of Poison Pill
2. LCA-Vision Adopts Stockholder Rights Plan
3. Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company
4. LCA-Vision to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
5. LCA-Vision Reports Third Quarter 2008 Financial Results
6. LCA-Vision Named Provider for New Insured Lasik Product
7. LCA-Vision Announces Upcoming Investment Community Events
8. LCA-Vision Provides Business Update and Market Review
9. LCA-Vision Announces CFO Change
10. LCA-Vision Announces Upcoming Investment Community Events
11. LCA-Vision Conducts 2008 Annual Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... feline DNA in virus , , SUNDAY, Dec. 6 (HealthDay News) ... be found in a tiger that lived thousands or millions ... the virus took on a bit of a tiger,s genetic ... in the virus to this day. That tiger, in fact, ... the virus that ultimately led to its infection of humans. ...
(Date:12/6/2009)... new study provides welcome news for patients with a ... , The condition is estimated to impact 62,000 Canadians ... abnormal clot forms in a vein and restricts the ... cases, the clot may detach from its point of ... causing a potentially fatal condition known as a pulmonary ...
(Date:12/5/2009)... NEW ORLEANS, Dec. 5 There have been significant ... leading experts continue to gain a better understanding of ... treatment options and provide patients with the best care. ... the American Society of Hematology explores optimal induction therapies ...
(Date:12/5/2009)... eliminate triggers, experts advise , , SATURDAY, Dec. 5 (HealthDay ... and asthma can have bad reactions to certain holiday ... sneezing and wheezing, according to the American College of ... allergic to live evergreens may choose to decorate with ...
(Date:12/5/2009)... unusual places, and to do everything from growing mushrooms, making wine to ... ... would have thought that your wine, water and vegetables would have come ... new line of turbines, for industry end users, not wind farms. ...
Breaking Medicine News(10 mins):Health News:AIDS May Date Back to Ancient Tiger 2Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3
... is what usually gets folks to this advanced age, ... -- Living longer, even past the 100-year mark, doesn,t ... spent in sickness or disability, Danish researchers report. ... lives despite their advanced age, the study found. , ...
... Inc. (OTC Bulletin Board: URGP, http://www.urigen.com ... development and,commercialization of treatments for urological disorders, ... has issued the first patent for the,use ... for,Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC). Patent number ...
... for life reach 210,000 cups sold by Labor Day ... 2008, First-of-its-kind virtual ... ... over, but the,fight to eliminate pediatric cancer charges ahead. The world,s first,virtual lemonade stand, ...
... LANSING, Mich., Aug. 19 Afid Therapeutics, Inc.,announced today ... vivo,(whole animal) demonstrations of the efficacy of its new ... applications. The,in vivo and some of the in vitro ... laboratory. Heparin is a complex drug, which is used,beyond ...
... Favor Stronger Coverage for Wheelchairs,Oxygen, and Other Home Medical ... Nearly three out of,four (74 percent) American voters agree ... problem of rapidly increasing Medicare spending for,America,s seniors." Voters ... A national telephone survey of 1,000 American adults ...
... new product specifically to use with the Gerbig Cleanroom systems. ... ... Engineering, a designer, fabricator and installer of http://www.gerbig.com [cleanrooms ... the AireCell line of modular cleanrooms. The product is an ...
Other Medicine News:Health News:Living to 100 Doesn't Mean Living Poorly 2Health News:Living to 100 Doesn't Mean Living Poorly 3Health News:Urigen Announces Issuance of Key Patent for URG101 - A Novel Therapy to Treat Painful Bladder Syndrome/Interstitial Cystitis 2Health News:Urigen Announces Issuance of Key Patent for URG101 - A Novel Therapy to Treat Painful Bladder Syndrome/Interstitial Cystitis 3Health News:Make an Impact on Pediatric Cancer Research Before Summer's End: Try Some Virtual Lemonade! 2Health News:Make an Impact on Pediatric Cancer Research Before Summer's End: Try Some Virtual Lemonade! 3Health News:Afid Therapeutics Inc.'s New Anticoagulant Heparin Replacement Passes in Vivo Test 2Health News:Republican and Democratic Voters View Home Care as a Solution to Rising Medicare Spending, Harris Survey Finds 2Health News:Republican and Democratic Voters View Home Care as a Solution to Rising Medicare Spending, Harris Survey Finds 3
(Date:12/4/2009)... ,, PHILADELPHIA, Dec. 4 Teamster members employed ... are hard at work educating the public about the ... put Philadelphia,s blood supply at risk. More than ... picket line yesterday when their issues were ignored by ...
(Date:12/4/2009)... Corporation (Nasdaq: DYNT ) announced it has signed ... rehab supplies to Benchmark Physical Therapy with 65 clinics ... pleased to be named the sole-source supplier to Benchmark ... of sales and marketing at Dynatronics. "Benchmark is known ...
(Date:12/4/2009)... FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: ... medication delivery company, today announced the launch of its ... intravenous (I.V.) medications and solutions, and now offers a ... the award-winning, environmentally responsible VisIV product. The launch of ...
Breaking Medicine Technology:Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4The Healthcare Scoop Community Says 26apos 3BEye Care 26apos 3B 50306 1The Healthcare Scoop Community Says 26apos 3BEye Care 26apos 3B 50306 2The Healthcare Scoop Community Says 26apos 3BEye Care 26apos 3B 50306 3Access Pharmaceuticals Announces Commercial Launch of MuGard 28TM 29 in Greece by SpePharm 50303 1Access Pharmaceuticals Announces Commercial Launch of MuGard 28TM 29 in Greece by SpePharm 50303 2Access Pharmaceuticals Announces Commercial Launch of MuGard 28TM 29 in Greece by SpePharm 50303 3Air Methods Petitions NTSB for Reconsideration of Probable Cause Determination 50300 1Air Methods Petitions NTSB for Reconsideration of Probable Cause Determination 50300 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: